PATEL SAMIR CHANDRAKANT
SEC insider (Form 3/4/5 filer). CIK 0001277966. Director at Kalaris Therapeutics, Inc. (KLRS). 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 10, 2025. Located in PALO ALTO, CA.
Companies PATEL SAMIR CHANDRAKANT has filed insider reports for
- Kalaris Therapeutics, Inc. (KLRS): Director
PATEL SAMIR CHANDRAKANT
CIK: 0001277966
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KLRS
Kalaris Therapeutics, Inc.
Director